Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Return on Assets [ROA] (2020 - 2026)

Updated

Kymera Therapeutics (KYMR) recorded Return on Assets [ROA] of -21.13% in Q2 2026, up 9.30 percentage points from -30.43% a year earlier but down 0.08 percentage points from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Kymera Therapeutics reported Return on Assets [ROA] of -25.68%, up 7.99 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of -10.35 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -33.68% in FY2024 (-5.59 pp), -28.08% in FY2023 (-1.41 pp), -26.68% in FY2022 (-8.28 pp) and -18.39% in FY2021 (-3.06 pp).
  • Quarterly Return on Assets [ROA] has ranged from -32.59% in Q3 2023 to -14.73% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +1.50 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 11.08 percentage points in Q3 2024, against a drop of 12.77 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -21.05% (Q1 2026), -24.56% (Q4 2025) and -29.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Kymera Therapeutics 8.89 Bn 6.19 Bn - -21.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.13%
Mar 31, 2026 -21.05%
Dec 31, 2025 -24.56%
Sep 30, 2025 -29.76%
Jun 30, 2025 -30.43%
Mar 31, 2025 -29.34%
Dec 31, 2024 -26.00%
Sep 30, 2024 -21.52%
Jun 30, 2024 -21.91%
Mar 31, 2024 -24.66%
Dec 31, 2023 -29.35%
Sep 30, 2023 -32.59%
Jun 30, 2023 -28.80%
Mar 31, 2023 -27.88%
Dec 31, 2022 -25.98%
Sep 30, 2022 -26.96%
Jun 30, 2022 -25.84%
Mar 31, 2022 -21.27%
Dec 31, 2021 -16.11%
Sep 30, 2021 -14.73%
API Access

Kymera Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEY